Martin Michels,Markus Follman,Alexandros Vakalopoulos,Katja Zimmermann,Nicole Teusch,Mario Lobell
申请号：
US13383223
公开号：
US20120190709A1
申请日:
2010.07.07
申请国别(地区):
US
年份:
2012
代理人:
摘要：
This invention relates to novel 4-(indazol-5-yl)-4,7-dihydroisoxazolo[5,4-b]pyridine derivatives having protein tyrosine kinase inhibitory activity, to a process for the manufacture thereof and to the use thereof for the treatment of c-Met-mediated diseases or c-Met-mediated conditions, particularly cancer and other proliferative disorders.
